Your SlideShare is downloading. ×
Consumer health in india
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Consumer health in india

504

Published on

Consumer healthcare emerges as a lucrative market …

Consumer healthcare emerges as a lucrative market
Vigorous efforts to push and update product offerings, combined with frequent weather changes and high pollution levels, as well as rising cases of seasonal infections and stressful lifestyles, all spurred the consumer healthcare industry in India. Demand for products like analgesics, cough and cold remedies and digestive remedies increased in rural areas in line with rising education levels and expanding distribution networks. Moreover, rising consumer sophistication and a growing awareness regarding both curative and preventative measures for minor health issues in urban areas created demand for lifestyle-related products, such as vitamins and dietary supplements, weight-loss supplements, sports nutrition and emergency contraception. The introduction of sophisticated formats for common ailments, such as sprays for topical pain management, acidity and nasal congestion also supported growth in consumer interest for consumer health care products throughout the year.

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
504
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
15
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Consumer Health in IndiaBuy Your Copy of Report @ http://www.reportsnreports.com/reports/166266-consumer-health-in-india.htmlReport Details:Published: June 2012Price Single user license: US $ 2400OverviewDiscover the latest market trends and uncover sources of future market growth for the ConsumerHealth industry in India with research from Euromonitors team of in-country analysts.Find hidden opportunities in the most current research data available, understand competitive threatswith our detailed market analysis, and plan your corporate strategy with our expert qualitative analysisand growth projections.If youre in the Consumer Health industry in India, our research will save you time and money whileempowering you to make informed, profitable decisions.When you purchase this report, you also get the data and the content from these category reports inIndia for free:Adult mouth careAnalgesicsCalming and sleepingCough, cold and allergy (hay fever) remediesDigestive remediesEar careEmergency contraception
  • 2. Eye careHerbal and traditional productsMedicated skin careNRT smoking cessation aidsOTC obesityOTC statinsOTC triptansSlimming productsSports nutritionVitamins and dietary supplementsWound treatmentsThe Consumer Health in India market research report includes:Analysis of key supply-side and demand trendsDetailed segmentation of international and local productsHistoric volumes and values, company and brand market sharesFive year forecasts of market trends and market growthRobust and transparent market research methodology, conducted in-countryOur market research reports answer questions such as:What is the market size of Consumer Health in India?What are the major brands in India?What are the main trends in OTC Healthcare?Why buy this report?Gain competitive intelligence about market leadersTrack key industry trends, opportunities and threats
  • 3. Inform your marketing, brand, strategy and market development, sales and supply functionsThis industry report originates from Passport, our Consumer Health market research database.Sample AnalysisEXECUTIVE SUMMARYConsumer healthcare emerges as a lucrative marketVigorous efforts to push and update product offerings, combined with frequent weather changes andhigh pollution levels, as well as rising cases of seasonal infections and stressful lifestyles, all spurred theconsumer healthcare industry in India. Demand for products like analgesics, cough and cold remediesand digestive remedies increased in rural areas in line with rising education levels and expandingdistribution networks. Moreover, rising consumer sophistication and a growing awareness regardingboth curative and preventative measures for minor health issues in urban areas created demand forlifestyle-related products, such as vitamins and dietary supplements, weight-loss supplements, sportsnutrition and emergency contraception. The introduction of sophisticated formats for commonailments, such as sprays for topical pain management, acidity and nasal congestion also supportedgrowth in consumer interest for consumer health care products throughout the year.Private label making efforts but remains the underdogPrivate label products continue to be in a nascent phase, with few major players operating in the field.At present, OTC private label products have not generated confidence among consumers and have animage of being a “me-too” version of established big names. Though private labels seek to offer qualityand innovation at an economical price, consumers have yet to accept such products because of lowawareness and limited availability in comparison to national brands. Apollo Hospitals Enterprises Ltd andGuardian Nutrition & Health Supplements Pvt Ltd are two major players which offer private labels.Chemists/pharmacies remain the largest source of businessChemists/pharmacies continue to lead consumer health product sales in India. Interestingly enough,direct sellers Amway and Herbalife are among the top three consumer health manufacturers and bothincreased share in 2011. Other channels, like supermarkets/hypermarkets, grocery retailers, gyms, otherhealthcare specialist retailers, internet retailing registered slow growth in the market, with the productsretailed through these outlets mainly being vitamins and dietary supplements, wound care and weightmanagement products. This is due to convenience, as consumers find it easier to shop for theirhealthcare products whilst grocery shopping or working out in a sports centre or gym.Competition remained fragmentedWith a large number of companies operating in the consumer healthcare business in the country,competition remained fragmented in 2011. While multinational companies have traditionally dominated
  • 4. the consumer healthcare environment, GlaxoSmithKline, Reckitt Benckiser, Johnson & Johnson, Procter& Gamble, Pfizer have found it difficult to penetrate into the herbal/traditional products market.Domestic companies like Dabur India, Emami Ltd, Himalaya Drug Co, Baidyanath, Hamdard lead in theherbal/traditional products category. The leading players benefit from the growing preference for self-medication, with consumers tending to opt for well-known brands from trusted manufacturers. Manysmall players operate in the herbal/traditional category, offering products to treat various healthproblems. This has increased the level of competition in the market.Weight management a star performer in the forecast periodAn obsession with weight and general appearance will help weight management products drive theconsumer health market in India. Euromonitor forecasts a strong CAGR of 19.7% in the forecast periodfor this sector. Similarly, Indian consumers are expected to become more accepting of self-remedy,especially for minor ailments. This will drive OTC product performance, ensuring its position as thelargest contributor to the consumer healthcare marketTable of ContentsConsumer Health in India - Industry OverviewEXECUTIVE SUMMARYConsumer healthcare emerges as a lucrative marketPrivate label making efforts but remains the underdogChemists/pharmacies remain the largest source of businessCompetition remained fragmentedWeight management a star performer in the forecast periodKEY TRENDS AND DEVELOPMENTSLarge-scale eye-catching promotions increase brand awarenessConsumers turning to herbal/traditional product offeringsSmaller packs and fast-acting formulas characterise brand developmentRising trend towards self-treatmentMore consumers believe in healthcare productsChemists/pharmacies continues to be the main channelTERRITORY KEY TRENDS AND DEVELOPMENTSEast and Northeast IndiaNorth India
  • 5. South IndiaWest IndiaRURAL VS URBAN KEY TRENDS AND DEVELOPMENTSMARKET INDICATORSTable 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011Table 2 Life Expectancy at Birth 2006-2011MARKET DATATable 3 Sales of Consumer Health by Category: Value 2006-2011Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011Table 5 Sales of Consumer Health by Region: Value 2006-2011Table 6 Sales of Consumer Health by Region: % Value Growth 2006-2011Table 7 Sales of Consumer Health by Rural-Urban % Value Analysis 2011Table 8 Consumer Health Company Shares 2007-2011Table 9 Consumer Health Brand Shares 2008-2011Table 10 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011Table 11 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011Table 12 Forecast Sales of Consumer Health by Category: Value 2011-2016Table 13 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016Table 14 Forecast Sales of Consumer Health by Region: Value 2011-2016Table 15 Forecast Sales of Consumer Health by Region: % Value Growth 2011-2016APPENDIXOTC registration and classificationVitamins and dietary supplements registration and classificationSelf-medication/self-care and preventative medicineSwitchesDEFINITIONSSOURCESSummary 1 Research SourcesConsumer Health in India - Company ProfilesAmrutanjan Health Care Ltd in Consumer Health (India)STRATEGIC DIRECTIONKEY FACTS
  • 6. COMPANY BACKGROUNDPRODUCTIONSummary 4 Amrutanjan Health Care Ltd: Production Statistics 2011COMPETITIVE POSITIONINGSummary 5 Amrutanjan Health Care Ltd: Competitive Position 2011Dabur India Ltd in Consumer Health (India)STRATEGIC DIRECTIONKEY FACTSCOMPANY BACKGROUNDPRODUCTIONSummary 8 Dabur India Ltd: Production Statistics 2011COMPETITIVE POSITIONINGSummary 9 Dabur India Ltd: Competitive Position 2011Emami Ltd in Consumer Health (India)STRATEGIC DIRECTIONKEY FACTSCOMPANY BACKGROUNDPRODUCTIONCOMPETITIVE POSITIONINGSummary 12 Emami Ltd: Competitive Position 2011Guardian Lifecare Pvt Ltd in Consumer Health (India)STRATEGIC DIRECTIONKEY FACTSCOMPANY BACKGROUNDPRODUCTIONCOMPETITIVE POSITIONINGHimalaya Drug Co, The in Consumer Health (India)STRATEGIC DIRECTIONKEY FACTSCOMPANY BACKGROUNDPRODUCTIONCOMPETITIVE POSITIONINGSummary 15 Himalaya Drug Co, The: Competitive Position 2011Procter & Gamble Hygiene & Health Care Ltd in Consumer Health (India)STRATEGIC DIRECTIONKEY FACTS
  • 7. COMPANY BACKGROUNDPRODUCTIONCOMPETITIVE POSITIONINGSummary 18 Procter & Gamble Hygiene & Healthcare Ltd: Competitive Position 2011Ranbaxy Laboratories Ltd in Consumer Health (India)STRATEGIC DIRECTIONKEY FACTSCOMPANY BACKGROUNDPRODUCTIONSummary 21 Ranbaxy Laboratories Ltd: Production Statistics 2011COMPETITIVE POSITIONINGSummary 22 Ranbaxy Laboratories Ltd: Competitive Position 2011Shree Baidyanath Ayurved Bhawan Pvt Ltd in Consumer Health (India)STRATEGIC DIRECTIONKEY FACTSCOMPANY BACKGROUNDPRODUCTIONCOMPETITIVE POSITIONINGSummary 24 Shree Baidyanath Ayurved Bhawan Pvt Ltd: Competitive Position 2011Adult Mouth Care in India - Category AnalysisHEADLINESTRENDSAdult mouth care is expected to remain dominated by doctors’ recommendations, due to a lack ofawareness among consumers. However, companies are making efforts to promote their products, whichwill help boost sales of OTC adult mouth care products. High stress and fast moving lifestyles arecontributing to an increased incidence of mouth ulcers, attributable to a deficiency of vitamin B. Urbanconsumption account for almost 85% of product sales.SWITCHESCOMPETITIVE LANDSCAPEManeesh Pharmaceuticals Pvt Ltd continued to lead the adult mouth care category in 2011, with a valueshare of 39%. Maneesh Pharmaceutical’s Smyle Mouth Ulcer Gel is well ahead of other brands such asZytee, Clohex and Betadine Gargle.PROSPECTS
  • 8. Adult mouth care products are expected to see growth in the forecast period, due to increasingawareness about these products among consumers, and major players promoting their productsthrough television advertising and other media sources, expanding their distribution networks acrossthe country. The growth of this category will also be driven by doctors who prescribe these products.CATEGORY DATATable 16 Sales of Adult Mouth Care: Value 2006-2011Table 17 Sales of Adult Mouth Care: % Value Growth 2006-2011Table 18 Adult Mouth Care Company Shares by Value 2007-2011Table 19 Adult Mouth Care Brand Shares by Value 2008-2011Table 20 Forecast Sales of Adult Mouth Care: Value 2011-2016Table 21 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016Analgesics in India - Category AnalysisHEADLINESTRENDSSelf-medication remained on the rise in 2011. Despite being informed regarding the dangers of overuseof systemic analgesics, consumers continued to use OTC products for mild pains. Media promotions byvarious companies, like GlaxoSmithKline and Piramal, have helped popularise systemic analgesics amongconsumers, who use them for mild pain and fever.SWITCHESCOMPETITIVE LANDSCAPEIn the systemic analgesics category, GlaxoSmithKline Consumer Healthcare’s Crocin and Calpol, Wyeth’sAnacin, Reckitt Benckiser’s Disprin, and Piramal Healthcare’s Saridon continue to be the front runners,while within topical analgesics, Zandu Balm leads with 18% of value, followed by Iodex, with 16%, andMoov, with 12%.PROSPECTSThe analgesics category will grow positively in the forecast period, due to consumers requiring the quickpain relief offered by analgesics, and penetration of these products into rural areas. Consumers arelooking for rapid relief from headaches, back ache and other pain, which will drive the growth ofanalgesics in the forecast period. Improved affordability and increased penetration ofchemists/pharmacies across rural areas will also help drive the analgesics category in the forecastperiod.CATEGORY DATA
  • 9. Table 22 Sales of Analgesics by Category: Value 2006-2011Table 23 Sales of Analgesics by Category: % Value Growth 2006-2011Table 24 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011Table 25 Analgesics Company Shares by Value 2007-2011Table 26 Analgesics Brand Shares by Value 2008-2011Table 27 Forecast Sales of Analgesics by Category: Value 2011-2016Table 28 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016Calming and Sleeping in India - Category AnalysisTRENDSOTC calming and sleeping product sales remained negligible in India in the review period. The majorityof calming and sleeping products are classified as prescription drugs. This category is expected to remainprescription based, as consumers prefer to consult a doctor, thus the prospects for OTC brands willcontinue to remain poor in the forecast period.Cough, Cold and Allergy (Hay Fever) Remedies in India - Category AnalysisHEADLINESTRENDSSeasonal weather changes, rapid temperature changes due to prolonged winters, and direct exposure toatmospheric pollutants were the major factors which supported the performance of cough, cold andallergy remedies in India during the review period. Not surprisingly, demand for these products peaksduring the winter.SWITCHESCOMPETITIVE LANDSCAPEProcter & Gamble Hygiene & Healthcare Ltd continued to lead category sales in 2011, with a value shareof 38%. The company was able to sustain its position due to the strong performance of its Vicks brand,which continued to perform well in 2011. Johnson & Johnson (India) Ltd held second place with a valueshare of 10% in 2011, followed by Cadbury India Ltd with a value share of 7%.PROSPECTSIn the forecast period, consumers are expected to gain more awareness of the OTC cough, cold andallergy remedy brands available on the market shelves. Consumers in India are slowly increasing theirreliance on self-medication, which will push demand for OTC cough and cold products in the market.This category is expected to witness growth in the future due to improved rural penetration of coughremedies and inhalant decongestants.
  • 10. CATEGORY DATATable 29 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011Table 31 Sales of Decongestants by Category: Value 2006-2011Table 32 Sales of Decongestants by Category: % Value Growth 2006-2011Table 33 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011Table 34 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011Table 35 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016Table 36 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth2011-2016Digestive Remedies in India - Category AnalysisHEADLINESTRENDSWith disposable incomes increasing and the changing lifestyles of people in India, consumers prefer toeat outside more, and greater consumption of “junk” food led to growth in digestive remedies in 2011.People in India prefer spicy and rich food, which can lead to stomach disorders, and with increasingawareness of digestive remedies brands and their benefits, consumers are opting for OTC productsinstead of visiting a doctor.SWITCHESCOMPETITIVE LANDSCAPEDabur India Ltd continued to lead sales of digestive remedies in 2011, with a value share of 35%,followed by Abbott India Ltd, with a 14% value share. Dabur is an established name in the ayurvedicmarket, and Indian consumers’ inclination towards natural remedies is supporting the company’sgrowth.PROSPECTSIncreased consumption of “junk” food and irregular eating habits in the forecast period will drivedemand for digestive remedies, such as indigestion and heartburn remedies. Antacids will see thesecond fastest growth in the forecast period, slower only to digestive enzymes due their availabilityacross Tier II cities and rural areas.CATEGORY DATATable 37 Sales of Digestive Remedies by Category: Value 2006-2011Table 38 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • 11. Table 39 Digestive Remedies Company Shares by Value 2007-2011Table 40 Digestive Remedies Brand Shares by Value 2008-2011Table 41 Forecast Sales of Digestive Remedies by Category: Value 2011-2016Table 42 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016Ear Care in India - Category AnalysisHEADLINESTRENDSThe ear being a sensitive organ, consumers prefer to consult a doctor for treating ear problems ratherthan self-medicating, to avoid the risk of hearing impairment or even hearing loss. Consumers buy UTCproducts which they are familiar with, or buy products recommended by a pharmacist. Even the OTCbrands rely significantly on suggestions of a doctor or chemist. Consumers who are aware of theseproducts buy them with doctors’ recommendation, but many other consumers do not treat earproblems unless the pain is very severe.SWITCHESCOMPETITIVE LANDSCAPENulife Pharmaceuticals Ltd, with its flagship brand Soliwax, continued to lead the ear care category in2011, with a 48% value share. It was followed by Bell Pharma Pvt Ltd with a 38% value share. There areother herbal and ayurvedic brands which hold very small shares in ear care.PROSPECTSEar care is a static product category in India, and the lack of an inclination among consumers to self-treat minor ear problems and a general absence of company activity will lead to a weak performance ofthis product category over the forecast period.CATEGORY DATATable 43 Sales of Ear Care: Value 2006-2011Table 44 Sales of Ear Care: % Value Growth 2006-2011Table 45 Ear Care Company Shares by Value 2007-2011Table 46 Ear Care Brand Shares by Value 2008-2011Table 47 Forecast Sales of Ear Care: Value 2011-2016Table 48 Forecast Sales of Ear Care: % Value Growth 2011-2016Emergency Contraception in India - Category AnalysisHEADLINES
  • 12. TRENDSEmergency contraception is gaining in popularity among modern women, who are turning to theseproducts to reduce the chances of an unwanted pregnancy in an easy manner. Major cities, includingDelhi NCR, Jaipur, Chandigarh, Kanpur and Lucknow are the major sources of demand for emergencycontraceptive brands in North India as the population of educated women is greater in these areas, andthey are using the product after unprotected intercourse to avoid pregnancy. Emergency contraceptionis mostly used by young women aged 18-30. Elsewhere, contraception is gaining traction thanks togreater focus on education.SWITCHESCOMPETITIVE LANDSCAPEPiramal Healthcare Ltd, with its flagship brand i-pill, continued to lead the emergency contraceptioncategory in 2011. Piramal accounted for 35% of value in 2011, followed by Mankind Pharma with a valueshare of 32%, with its band Unwanted 72.PROSPECTSWith changing lifestyles and attitudes among women, especially in the urban areas, it is expected thatthis category has strong growth prospects over the forecast period, as it is seen as easy and convenientoption to avoid unwanted pregnancy. The players in this category will have to look for new options forpromoting their products, as the government has imposed a ban on advertising.CATEGORY DATATable 49 Sales of Emergency Contraception: Value 2008-2011Table 50 Sales of Emergency Contraception: % Value Growth 2008-2011Table 51 Emergency Contraception Company Shares by Value 2007-2011Table 52 Emergency Contraception Brand Shares by Value 2008-2011Table 53 Forecast Sales of Emergency Contraception: Value 2011-2016Table 54 Forecast Sales of Emergency Contraception: % Value Growth 2011-2016Eye Care in India - Category AnalysisHEADLINESTRENDSThere are very few OTC eye care brands available in India. The only notable brand during 2011 washerbal product, I-Tone, from Dey’s Medical Stores (Mfg) Ltd. There are, however, many players whichcome and go.
  • 13. SWITCHESCOMPETITIVE LANDSCAPEThe OTC eye care category is dominated by three players: Dey’s Medical (I-Tone brand), OzoneAyurvedic (Itis) and Diamond eye drops. There are many small players – mostly ayurvedic – present inthe market but they do not have a significant impact on the eye care category.PROSPECTSIt is predicted that there will be steady growth in the eye care category, as no major change isanticipated in consumers’ behaviour towards the OTC eye care products present in the market. WithBausch & Lomb planning to launch two or three OTC eye care products in early 2012, the standard eyecare category is expected to see growth in the forecast period.Herbal/Traditional Products in India - Category AnalysisHEADLINESTRENDSHerbal/traditional products are seeing a rise in demand in India, as these products are considered safeand healthy, with less potential for side effects than standard products. Herbal/traditional products arepopular across various categories, ranging from cough medicines, dietary supplements and digestiveremedies to topical analgesics.COMPETITIVE LANDSCAPEEmami Ltd continued to lead in herbal/traditional products in 2011, with a 19% value share. Thecompany became number after acquiring Zandu Balm in 2009. It offers a wide variety ofherbal/products, including Emami Mentho Plus, Boroplus and Himani Chyawanprash. Dabur India Ltd isthe second largest player in herbal/traditional products with a value share of 16% in 2011. Dabur haspopular herbal brands such as Hajmola, Dabur Honitus and Pudin Hara. The third largest player isProcter & Gamble Hygiene & Health Care Ltd, with a value share of 12% in 2011. Its most popular brandis Vicks, which is available in different formats.PROSPECTSHerbal/traditional products is expected to post a stronger performance over the forecast period, asconsumers are tending to prefer such products due to their natural ingredients and safer options withno side effects. With increasing consumer awareness and health consciousness, due to government andmanufacturers’ educational and advertising campaigns, more consumers will start consumingherbal/traditional products over the forecast period.
  • 14. CATEGORY DATATable 55 Sales of Herbal/Traditional Products: Value 2006-2011Table 56 Sales of Herbal/Traditional Products: % Value Growth 2006-2011Table 57 Herbal/Traditional Products Company Shares 2007-2011Table 58 Herbal/Traditional Products Brand Shares 2008-2011Table 59 Forecast Sales of Herbal/Traditional Products: Value 2011-2016Table 60 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016Medicated Skin Care in India - Category AnalysisHEADLINESTRENDSTopical germicidals/antiseptics are mainly used in the winter, but are not liked by many consumers dueto the stickiness of the creams. Topical antifungals and antiparasitics register the strongest demand inthe summer. Increased consumption of antiparasitics, hair loss treatments and medicated shampooproducts among lower middle class households is enhancing sales of such products across India.SWITCHESCOMPETITIVE LANDSCAPEEmami Ltd continues to lead in medicated skin care, with its flagship brand Himani Boroplus. It had avalue share of 42% in 2011, followed by GD Pharmaceuticals Pvt Ltd with a value share of 9% andJohnson & Johnson with a value share of 8%.PROSPECTSMedicated skin care will continue to see growth in the forecast period, driven by factors including theincreasing preference of consumers to self-medicate for minor skin problems, and more stressfullifestyles. Private label brands such as Boro Life from Apollo Pharmacy are expanding, which will putpressure on the existing brands.CATEGORY DATATable 61 Sales of Medicated Skin Care by Category: Value 2006-2011Table 62 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011Table 63 Medicated Skin Care Company Shares by Value 2007-2011Table 64 Medicated Skin Care Brand Shares by Value 2008-2011Table 65 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016Table 66 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
  • 15. NRT Smoking Cessation Aids in India - Category AnalysisHEADLINESTRENDSIndia is the second largest tobacco consuming market in the world, with more than 120 million smokers,and growth is not showing any signs of slowing down. The government’s anti-smoking efforts, like acomplete ban on smoking in public places and campaigns/activities to show the ill effects of smoking,are expected to have a positive impact on NRT smoking cessation aids.SWITCHESCOMPETITIVE LANDSCAPEThere were only two companies offering NRT smoking cessation products in 2011. Johnson & Johnson’sNicorette was the most prominent brand, followed by Nulife Chewettes by Ceejay Healthcare Ltd.PROSPECTSWith Johnson & Johnson India Ltd investing substantial amounts in its advertising and promotionalactivities, NRT products are expected to see an increase in value sales in the forecast period. Greaterawareness among urban households and the health conscious consumer base will enhance sales of NRTproducts in the forecast period.Sports Nutrition in India - Category AnalysisHEADLINESTRENDSThe customer base for sports nutrition products in India remains very small, with awareness of theseproducts limited to hard core gym-goers, personal trainers, athletes and body builders. The high pricesof these products made it even harder to go mainstream and attract other consumers towards usingthese products during the most part of the review period. Most sports nutrition products are sold inunorganised channels; for example, some products like mass gainer supplements are sold by gymtrainers directly to the end customer.COMPETITIVE LANDSCAPECoach’s Formula, by Plethico India Ltd, and Endura Mass, by Medinn Belle Herbal Care Pvt Ltd, wereamongst the leading brands in 2011.PROSPECTS
  • 16. As the number of health conscious people is increasing in India, demand for sports nutrition products isexpected to emerge as a key growth area in the forecast period. However, these products areconsidered expensive and are not affordable for the majority of middle class consumers, which isexpected to impede full potential demand in the short-term.Vitamins and Dietary Supplements in India - Category AnalysisHEADLINESTRENDSConsumers in India are becoming more aware of health and wellness, which is driving demand forvitamins and dietary supplements. Consumers are prepared to pay premium prices for health andwellness products.VITAMINSDIETARY SUPPLEMENTSCOMPETITIVE LANDSCAPEAmway India Enterprises is the market leader in vitamins and dietary supplements, with a value share of24% in 2011. The company owes its position to its flagship brand Nutrilite, which has a strong presencein all the major categories, including protein powder, child-specific vitamins and dietary supplements,multivitamins and combination dietary supplements. The company extended its brand portfolio with thelaunch of the child-specific Nutrilite range, which helped to increase its value share in 2011. Dabur Indiawas the second largest company in this category with a value share of 11% in 2011.PROSPECTSWith changing dietary habits and the increasing popularity of food options deficient in vital nutrients, itis expected that there will be a significant rise in demand for vitamins and dietary supplement productsin India. Consumers will start paying more attention to their general health and wellbeing bysupplementing their diets. Key players enhancing their promotional activities will increase awarenessamong consumers, which will help drive demand for vitamins and dietary supplement products in theforecast period.CATEGORY DATATable 67 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011Table 68 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011Table 69 Dietary Supplements by Positioning 2006-2011Table 70 Vitamins and Dietary Supplements Company Shares by Value 2007-2011Table 71 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • 17. Table 72 Vitamins Brand Shares by Value 2008-2011Table 73 Dietary Supplements Brand Shares by Value 2008-2011Table 74 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016Table 75 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016Weight Management in India - Category AnalysisHEADLINESTRENDSThe Diabetes Foundation of India and the National Diabetes, Obesity and Cholesterol Foundation (N-DOC) conducted a survey involving school students, which revealed that at least 32.6% studentsstudying in private schools and 9.6% in government schools are obese. The particularly high figures inDelhi, Mumbai, Kolkata, Lucknow and Bangalore are due to irregular eating habits, unbalanced diets anda lack of exercise. Demand for weight management products will continue to rise due to escalatingobesity rates and the rise of image consciousness among Indians.COMPETITIVE LANDSCAPEHerbalife International India Pvt Ltd led sales in 2011. The company’s flagship brand Shapeworksrecorded a value share of 74% in 2011, putting the company some way ahead of the second largestplayer. Amway India Enterprises was in second position with a value share of 6%, with its brand Positrimin 2011. The third largest player in this category was Himalaya Drug Co, with a value share of 3%, with itsbrand Ayurslim. The other major players include Sanat Products, with its brand Sunova Bioslim, andGoodcare Pharma Pvt Ltd, with its brand Ezi Slim.PROSPECTSWeight management products will see growth in the future, driven by sedentary lifestyles, rich eatinghabits and longer working hours, which will lead to an increase in the obese population in the forecastperiod.CATEGORY DATATable 76 Sales of Weight Management: Value 2006-2011Table 77 Sales of Weight Management: % Value Growth 2006-2011Table 78 Weight Management Company Shares 2007-2011Table 79 Weight Management Brand Shares 2008-2011Table 80 Forecast Sales of Weight Management: Value 2011-2016Table 81 Forecast Sales of Weight Management: % Value Growth 2011-2016Wound Care in India - Category Analysis
  • 18. HEADLINESTRENDS2011 value growth was lower than the review period CAGR of 7%. The low growth was predominantlydue to a return of traditional habits in Tier II and Tier III cities, where consumers tend to leave cuts opento heal quickly and on their own, even if these leave scars.COMPETITIVE LANDSCAPEJohnson & Johnson India Ltd continued to be the category leader in 2011, with a value share of 71%,followed by Beiersdorf India Ltd with a 21% value share. Johnson & Johnson’s brands Band-Aid andDynacrepe are available across all distribution channels, including in rural areas, which helped it retainthe number one position in 2011.PROSPECTSThe ease of using wound care products and the increasing need to be “on the go” for daily routineswithout hindrance from cuts and bruises are two major factors which are expected to escalate demandfor wound care in the forecast period. Manufacturers are likely to segment their offer, for example withproducts specifically for children, in order to increase sales and market penetration.CATEGORY DATATable 82 Sales of Wound Care by Category: Value 2006-2011Table 83 Sales of Wound Care by Category: % Value Growth 2006-2011Table 84 Wound Care Company Shares by Value 2007-2011Table 85 Wound Care Brand Shares by Value 2008-2011Table 86 Forecast Sales of Wound Care by Category: Value 2011-2016Table 87 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016Browse Complete Report @ http://www.reportsnreports.com/market-research/healthcare/Contact Us:TX, Dallas North - Dominion Plaza,17304, Preston Road,Suite 800, Dallas 75252.+ 1 888 391 5441Email: sales@reportsandreports.comConnect With Us:

×